Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
297.20    11.80 (4.13%)
Bid:
297.00
Ask:
297.40
Spread: 0.40 (0.135%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Update

20 Nov 2025 07:00

RNS Number : 2571I
Breedon Group PLC
20 November 2025
 

20 November 2025

BREEDON GROUP PLC

 

Trading Update to 31 October 2025

 

Resilient performance despite sustained market challenges

 

Breedon Group plc ("Breedon" or the "Group"), a leading vertically-integrated construction materials group in Great Britain, Ireland and the United States, provides the following trading update for the ten months to 31 October 2025.

Trading performance

When compared to the same period in 2024, revenue for the first ten months increased 9% and for the four months to 31 October increased 12% assisted by contributions from acquisitions. On a like-for-like1 basis revenue decreased 3% in the first ten months and decreased 3% for the four months to 31 October, consistent with the trends reported to the half year.

Market challenges have persisted to date in 2025. Subdued demand in GB and US residential markets have been compounded by key infrastructure project delays in GB and Ireland. Against this backdrop the Group has continued to focus on the integration of Lionmark and self-help, together with operational and commercial excellence initiatives.

Trading in GB has seen subdued demand in the year to date and near term construction activity expectations have reduced2. While our enquiries remain elevated they have not yet converted into orders. 

Trading in Ireland has been impacted by the deferral of some major infrastructure projects however the market in the Republic of Ireland has an encouraging outlook following the publication of the National Development Plan earlier this year2. 

In the US, while the business has made up some of the work delayed by weather in the first half, market growth expectations have moderated as the year has progressed2. Our US backlogs however are healthy and infrastructure markets in the Midwest remain encouraging with significant projects such as the I-70 progressing. New build residential continues to be subdued due to affordability constraints.

Despite market conditions we expect to deliver a further year of profitable growth with Underlying EBITDA for the year of between £275 to £280 million and a reduction in Covenant Leverage3 at the year end.

Outlook

In the medium term we are encouraged by the UK Government's commitment to infrastructure and housebuilding which will lead to increased demand for construction materials as market activity improves. However, at present there is considerable economic and fiscal uncertainty in the UK.

The National Development Plan in the Republic of Ireland represents a significant increase in potential infrastructure investment which we will be well placed to benefit from over the next few years. 

In the US, there remains considerable opportunity to build out our business with upside from residential when activity returns. In the near term, while non-residential and infrastructure markets remain resilient, market growth expectations have moderated.

Rob Wood, Chief Executive Officer, commented:

"Breedon continues to deliver resilient performance despite sustained market challenges. Our focus on operational and commercial excellence and strategic execution has continued to deliver profitable growth. We remain confident in the Group's prospects with our key end-markets across each of our geographies standing to benefit from long-term structural growth drivers. 

"While there is still uncertainty about the timing of a market recovery, particularly in the UK, we have an excellent team, three leading platforms and a well invested estate. We remain well placed to take advantage of any improvement in construction market activity."

 

Trading update conference call

Breedon will host a conference call at 08:00am for analysts and institutional investors, with a facility for Q&A. For details, please contact breedon@mhpgroup.com.

 

 

 

 

 

Notes:

1. Like-for-like reflects reported values adjusted for the impact of acquisitions, disposals and material currency fluctuations. Currency fluctuations are calculated on a constant currency basis by applying the average exchange rate for the prior period to the current year local currency amount.

2. Market data forecast references:

a. UK: CPA Autumn 2025, MPA September 2025, S&P Global UK Construction PMI October.

b. RoI: AIB Ireland Construction PMI October, 99th Euroconstruct.

c. US: FMI North American Engineering and Construction outlook Q4 2025.

3. Covenant Leverage reported at the Half Year was 2.2x. Covenant Leverage is defined as the ratio of Underlying EBITDA to Net Debt, with both Underlying EBITDA and Net Debt amended to reflect the material items which are adjusted by the Group and its lenders in determining leverage for the purpose of assessing covenant compliance. The material adjusting items being the impact of IFRS 16 and a pro-forma adjustment to include pre-acquisition EBITDA from businesses owned for less than twelve months. 

4.

Exchange rates

10-month 2025

10-month 2024

FY 2024

Period-end

Average

Period-end

Average

Period-end

Average

Sterling/Euro

1.14

1.17

1.20

1.18

1.21

1.18

Sterling/US dollar

1.32

1.32

1.30

1.28

1.26

1.29

 

 

 

 

 

 

 

5. Company compiled consensus: FY 2025 EBITDA £286.9m, range £278.9m to £292.0m.

6. Information for investors, including analyst consensus estimates, can be found on the Group's website at www.breedongroup.com/investors.

 

 

 

 

ENQUIRIES

Breedon Group plc

+44 (0) 1332 694010

Rob Wood, Chief Executive Officer

James Brotherton, Chief Financial Officer

Louise Turner-Smith, Head of Investor Relations

+44 (0) 7860 911909

MHP (Public relations adviser)

+44 (0) 7831 406117

Reg Hoare, Rachel Farrington, Charles Hirst

 

breedon@mhpgroup.com

 

 

 About Breedon Group plc

Breedon Group plc, a leading vertically-integrated construction materials group in Great Britain, Ireland and the United States delivers essential products to the construction sector. Breedon holds c.1.6bn tonnes of mineral reserves and resources with long reserve life, supplying value-added products and services, including specialty materials, surfacing and highway maintenance operations, to a broad range of customers through its extensive local network of quarries, ready-mixed concrete and asphalt plants.

 

The Group's two well-invested cement plants are actively engaged in a number of carbon reduction practices, which include utilising alternative raw materials and lower carbon fuels. Breedon's 4,900 colleagues embody our commitment to 'Make a Material Difference' as the Group continues to execute its strategy to create sustainable value for all stakeholders, delivering growth through organic improvement and acquisition in the heavyside construction materials market. Breedon shares (BREE) are traded on the Main Market of the London Stock Exchange and are a constituent of the FTSE 250 index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKRWRVRUAAAA
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.